The actual device was not available; however, photographs and a video of the sample were provided for evaluation.
Visual inspection of the provided video identified an external leak.
The reported condition was verified.
As the actual device was not returned, the cause of the condition could not be determined.
A batch review was conducted and there were no deviations found related to this reported condition during the manufacture of this lot.
Should additional relevant information become available, a supplemental report will be submitted.
Prismaflex st150 set c has been temporarily approved for use in the us under emergency use authorization eua(b)(4) to deliver crrt to treat patients in an acute care environment during the covid-19 pandemic.
|